Sharon A. Glied's Insider Trades & SAST Disclosures

Sharon A. Glied's most recent trade in NRX Pharmaceuticals Inc was a trade of 162,660 Employee Stock Option done . Disclosure was reported to the exchange on Oct. 21, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
NRX Pharmaceuticals Inc
Sharon A. Glied Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2022 162,660 228,097 - - Employee Stock Option
NRX Pharmaceuticals Inc
Sharon A. Glied Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 65,437 65,437 - - Employee Stock Option (Right to buy)
NRX Pharmaceuticals Inc
Sharon A. Glied Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 13,168 13,168 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades